Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127870291 | 12787029 | 1 | I | 20160919 | 20160927 | 20160927 | EXP | US-ASTRAZENECA-2016SF00756 | ASTRAZENECA | 61.00 | YR | F | Y | 0.00000 | 20160928 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127870291 | 12787029 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | 100.0MG UNKNOWN | 20541 | 100 | MG | TABLET | |||||||
| 127870291 | 12787029 | 2 | SS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | 0 | INJECTION | |||||||||
| 127870291 | 12787029 | 3 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | U | U | 0 | CAPSULE | ||||||||
| 127870291 | 12787029 | 4 | C | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127870291 | 12787029 | 5 | C | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127870291 | 12787029 | 6 | C | TAXOL | PACLITAXEL | 1 | 0 | ||||||||||||
| 127870291 | 12787029 | 7 | C | XGEVA | DENOSUMAB | 1 | EVERY THREE MONTHS | 0 | |||||||||||
| 127870291 | 12787029 | 8 | C | XGEVA | DENOSUMAB | 1 | EVERY THREE MONTHS | 0 | |||||||||||
| 127870291 | 12787029 | 9 | C | LETROZOLE. | LETROZOLE | 1 | 0 | ||||||||||||
| 127870291 | 12787029 | 10 | C | THYMERSOL | 2 | 0 | |||||||||||||
| 127870291 | 12787029 | 11 | C | DOXYCYLLINE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127870291 | 12787029 | 2 | Breast cancer metastatic |
| 127870291 | 12787029 | 3 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127870291 | 12787029 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127870291 | 12787029 | Back pain | |
| 127870291 | 12787029 | Hot flush | |
| 127870291 | 12787029 | Lymphoedema | |
| 127870291 | 12787029 | Malignant neoplasm progression | |
| 127870291 | 12787029 | Metastases to bone | |
| 127870291 | 12787029 | Pulmonary mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127870291 | 12787029 | 1 | 200910 | 0 | ||
| 127870291 | 12787029 | 2 | 201311 | 201603 | 0 | |
| 127870291 | 12787029 | 3 | 20160610 | 0 | ||
| 127870291 | 12787029 | 7 | 201311 | 0 | ||
| 127870291 | 12787029 | 8 | 201603 | 0 | ||
| 127870291 | 12787029 | 9 | 20160610 | 0 |